TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01539876 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04660344 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00000769 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT05428709 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00000851 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05957081 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412
Study NCT05034679 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05034679 — Predictive Biomarker (PRD): HSPG2 mRNA
Genes: HSPG2
Study NCT06356376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05198544 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04861259 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05916911 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT05494424 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06499974 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study NCT05970887 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04782622 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT05699785 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06300801 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05258669 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06538818 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05661916 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06245278 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04811664 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05260346 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05260346 — Safety Biomarker (SAF): BDNF
Study NCT05422976 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06527729 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT06527729 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06527729 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT06527729 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06600906 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05242315 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06656624 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05902728 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05491122 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT05864352 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06056921 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05353803 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05756699 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06422403 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06499571 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06320509 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05990803 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT05097911 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study NCT06242522 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05977465 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06544577 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06061614 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05035836 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05753397 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06349343 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06349343 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05773391 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04899648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05841472 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05841472 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04720157 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05036811 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04785820 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04785820 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study NCT04785820 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05218499 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT06042894 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT06042894 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06480591 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study NCT06480591 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05261399 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05261399 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06133088 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06133088 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06133088 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05675436 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06171594 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06097780 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT06097780 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06651151 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06083857 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05327894 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05664750 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05136196 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT05925608 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05531045 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05756764 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04923893 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05012566 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04647487 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04647487 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04961229 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05911282 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05911282 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04964934 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04964934 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04964934 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04696653 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05054842 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05052203 — Predictive Biomarker (PRD): SGCA mRNA
Genes: SGCA; ADL; DAG2
Study NCT05908734 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05908734 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04936308 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05817214 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04720261 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT05718115 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05268731 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT04918407 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04676360 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05826080 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT06528353 — Monitoring Biomarker (MOI): Circulating tumor HPV DNA
Study NCT06528353 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05943496 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05943496 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06502535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06169124 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05084651 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04842825 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06451822 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05986071 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05986071 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05986071 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05048147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06388733 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04385940 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT06788548 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT06188520 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05950724 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04788472 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04788472 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04669535 — Predictive Biomarker (PRD): HEXA mRNA
Genes: HEXA
Study NCT05582694 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04857502 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05560308 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06640881 — Predictive Biomarker (PRD): APOBEC3C mRNA
Genes: APOBEC3C; APOBEC1L; PBI
Study NCT06640881 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06640881 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06178302 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05336409 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05383053 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06282692 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05146869 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05297890 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05321069 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05719142 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT06584578 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06146114 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06188832 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT06188832 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT06188832 — Predictive Biomarker (PRD): LEPROT mRNA
Genes: LEPROT; LEPR; OBR
Study NCT05879224 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT05580926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05069038 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05069038 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04253132 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05876832 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06662786 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06662786 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT05155137 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06789367 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06789367 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT06783348 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05989347 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05020704 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06642480 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT06790212 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06789640 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06585501 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06788743 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05806333 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05806333 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04373603 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06789536 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT06186440 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06789900 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06208761 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06208761 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05058937 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT05058937 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06177041 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05748171 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06524544 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT04780659 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06215716 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT06766305 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05418712 — Predictive Biomarker (PRD): NAV1 mRNA
Genes: NAV1; KIAA1151; KIAA1213; POMFIL3; STEERIN1
Study NCT06328387 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06769685 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT06769685 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT06406153 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05516212 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study NCT05516212 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT05730036 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05240144 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05528952 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06479785 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05180825 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06789328 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06789328 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT06789471 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06789471 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06789471 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06175702 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06175702 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06365593 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06633224 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study NCT05153460 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04873349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04873349 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05913596 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05913596 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04939454 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT04939454 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05807711 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06473844 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06039527 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05076591 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06789107 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06110585 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06110585 — Safety Biomarker (SAF): BDNF
Study NCT06788314 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06284486 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT04512261 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05619770 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT06429098 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MYH11 mRNA
Genes: MYH11; KIAA0866
Study NCT05972421 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06788912 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06091774 — Predictive Biomarker (PRD): KHK mRNA
Genes: KHK
Study NCT06091774 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05394142 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT06499415 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT06504381 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06148272 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04688983 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04688983 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05952427 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06788470 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06788275 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06788275 — Safety Biomarker (SAF): BDNF
Study NCT06788340 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT06163833 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06163833 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT06789081 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT06788964 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06788613 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT04171817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04663997 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06788353 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT06789913 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT06789952 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06351150 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05145296 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05145296 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05400330 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05400330 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05967780 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06568939 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04561180 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05859958 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT06547879 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06483555 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06483555 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04701307 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05849922 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03842865 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05173103 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05173103 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05173103 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06131424 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06131424 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06131424 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06131424 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06131424 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05106790 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04674163 — Predictive Biomarker (PRD): MAPK7 mRNA
Genes: MAPK7; BMK1; ERK5; PRKM7
Study NCT04674163 — Predictive Biomarker (PRD): PKM mRNA
Genes: PKM; OIP3; PK2; PK3; PKM2